Followers | 240 |
Posts | 12050 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Thursday, October 23, 2014 11:09:01 AM
RYE, N.Y.--(BUSINESS WIRE)--The Gabelli Equity Trust (the “Fund”) is pleased to announce the completion of its transferable rights offering (the “Offering” or “Offer”) in which more than 27.4 million shares of common stock will be issued, totaling approximately $157 million. Pursuant to the Offer, the Fund issued one transferable right (a “Right”) for each share of common stock of the Fund to shareholders of record (record date shareholders) as of September 19, 2014. Holders of Rights were entitled to purchase one share of common stock by submitting seven Rights and $5.75 per share (the subscription price). The Offer expired at 5:00 PM Eastern Time on October 20, 2014 and the Rights no longer trade on the NYSE.
Preliminary results indicate that the Fund received total subscriptions of approximately $214 million (including over-subscription requests and notices of guaranteed delivery) for 136% of the 27,405,612 shares available to be issued pursuant to the primary subscription. Roughly two-thirds of the shares to be issued were subscribed for in the primary subscription. The over-subscription requests exceeded the over-subscription shares available. As a result, the available over-subscription shares will be allocated pro rata among those fully exercising record date shareholders based on the number of Rights originally issued to them by the Fund. The new shares of common stock will be issued on October 27, 2014.
We thank all the full service brokers and financial advisers who assisted our shareholders and their clients throughout the $157 million rights offering.
The Gabelli Equity Trust Inc. is a non-diversified, closed-end management investment company with $1.6 billion in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (NYSE:GBL).
Investors should consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. The base prospectus contains this and additional information about the Fund and the prospectus supplement will contain this and additional information about the Offering, and should be read carefully before investing.
Contacts
For The Gabelli Equity Trust
Molly Marion / Carter Austin, 914-921-5070
http://www.businesswire.com/news/home/20141022006433/en/Gabelli-Equity-Trust-%E2%80%93-NYSEGAB-Shareholders-Rights#.VEkZxYl0yUk
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent GAB News
- Gabelli Equity Trust 10% Distribution Policy Reaffirmed And Declared First Quarter Distribution Of $0.15 Per Share • GlobeNewswire Inc. • 02/14/2024 02:11:30 PM
- Gabelli Equity Trust Extends Expiration Date of Tender Offer to January 5, 2024 for Series C and Series E Auction Rate Preferred Stock • GlobeNewswire Inc. • 12/11/2023 10:04:00 PM
- Gabelli Equity Trust Commences Tender Offer for Series C and Series E Auction Rate Preferred Stock • GlobeNewswire Inc. • 11/22/2023 09:52:17 PM
- Gabelli Equity Trust 10% Distribution Policy Reaffirmed and Declared Fourth Quarter Distribution of $0.15 Per Share • GlobeNewswire Inc. • 11/16/2023 01:43:19 PM
- Gabelli Equity Trust 10% Distribution Policy Reaffirmed and Declared Third Quarter Distribution of $0.15 Per Share • GlobeNewswire Inc. • 08/25/2023 12:05:10 PM
- UPDATE - Gabelli Funds Presents Talkin’ ‘Bout 3 Generations of Dinsmore Convertible Management • GlobeNewswire Inc. • 07/18/2023 08:30:00 PM
- UPDATE - Gabelli Funds Presents Back to the Future with Closed-End Funds • GlobeNewswire Inc. • 06/02/2023 01:05:00 PM
- Gabelli Equity Trust 10% Distribution Policy Reaffirmed and Declared Second Quarter Distribution of $0.15 Per Share • GlobeNewswire Inc. • 05/18/2023 01:18:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM